Immune Design Corp.
IMDZ
IMDZ was delisted on the 1st of April, 2019.
48 hedge funds and large institutions have $210M invested in Immune Design Corp. in 2015 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 21 increasing their positions, 8 reducing their positions, and 5 closing their positions.
163% more repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 8
140% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 5
17% more funds holding
Funds holding: 41 → 48 (+7)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
29% less capital invested
Capital invested by funds: $294M → $210M (-$84.3M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RIM
RS Investment Management
San Francisco,
California
|
+$5.84M |
| 2 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
+$3.38M |
| 3 |
IHM
Iguana Healthcare Management
New York
|
+$2.61M |
| 4 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
+$2.14M |
| 5 |
BA
BlackRock Advisors
Wilmington,
Delaware
|
+$1.55M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PAI
ProQuest Associates IV
Naples,
Florida
|
-$7.35M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$1.23M |
| 3 |
NI
Numeric Investors
Boston,
Massachusetts
|
-$1.14M |
| 4 |
JP Morgan Chase
New York
|
-$676K |
| 5 |
HLA
Hamilton Lane Advisors
Conshohocken,
Pennsylvania
|
-$665K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
51
UBS Group
Zurich,
Switzerland
| – | -$26K | -832 | Closed |
|
52
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| – | +$183 | +7 | +233% |
|
53
Bank of America
Charlotte,
North Carolina
| – | +$418 | +16 | New |
|
IMDZ Hedge Fund Activity: Q1 2015 in Review
48 of the 3,754 institutional investors tracked by Wall St. Rank reported a position in Immune Design Corp. (IMDZ) for Q1 2015, worth a combined $210M — down 29% from $294M a quarter earlier.
Buyers outnumbered sellers: 12 funds opened new IMDZ positions and 5 closed out — a net gain of 7 holders — while 21 added to existing stakes and 8 trimmed.
The largest buyer was RS Investment Management, adding an estimated $5.84M. The largest seller was ProQuest Associates IV, cutting an estimated $7.35M.
- 48 institutional investors held Immune Design Corp. (IMDZ) as of Q1 2015, up from 41 in Q4 2014.
- Funds reported $210M of Immune Design Corp. stock for Q1 2015, down 29% quarter-over-quarter.
- 12 funds opened new Immune Design Corp. positions in Q1 2015 and 5 closed out, a net change of +7 holders.
- The largest Immune Design Corp. buyer in Q1 2015 was RS Investment Management, an estimated $5.84M added.
- The largest Immune Design Corp. seller in Q1 2015 was ProQuest Associates IV, an estimated $7.35M sold.
Based on aggregated 13F filings for Q1 2015.